Td Ameritrade Investment Management, LLC Abb Vie Inc. Transaction History

Td Ameritrade Investment Management, LLC

$0
Q3 2023

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $277,199 - $320,898	-2,075 Closed	0 $0
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $45,980 - $57,220	-347 Reduced 14.33%	2,075 $280,000
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $87,778 - $101,089	-607 Reduced 20.04%	2,422 $386,000
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $283,950 - $340,531	-2,053 Reduced 40.4%	3,029 $490,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $135,283 - $155,161	-1,008 Reduced 16.55%	5,082 $682,000
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $381,895 - $485,514	-2,775 Reduced 31.3%	6,090 $933,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $86,974 - $107,911	659 Added 8.03%	8,865 $1.44 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $61,557 - $77,887	573 Added 7.51%	8,206 $1.11 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $14,683 - $16,667	138 Added 1.84%	7,633 $669,000
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $127,619 - $142,175	1,213 Added 19.31%	7,495 $844,000
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $108,741 - $146,813	-1,351 Reduced 17.7%	6,282 $673,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $74,913 - $87,923	-872 Reduced 10.25%	7,633 $669,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $165,669 - $221,690	-2,258 Reduced 20.98%	8,505 $835,000
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $173,634 - $263,250	-2,692 Reduced 20.01%	10,763 $820,000
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $241,419 - $302,066	3,347 Added 33.11%	13,455 $1.19 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $97,052 - $116,684	1,541 Added 17.99%	10,108 $765,000
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $65,700 - $83,980	1,000 Added 13.22%	8,567 $623,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $181,973 - $214,173	2,359 Added 45.3%	7,567 $610,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $133,357 - $164,465	1,713 Added 49.01%	5,208 $480,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $247,703 - $275,368	2,786 Added 392.95%	3,495 $331,000
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $63,654 - $75,317	709 New	709 $66,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.

Account